Reuters UK Business

By James Davey LONDON (Reuters) – Apart from German-owned discounter Lidl GB, Marks & Spencer was Britain’s fastest growing supermarket in the Christmas quarter, industry data published on Tuesday showed. Researcher NIQ said M&S’s food sales on a value basis rose 12.1% in the 12 weeks to Dec. 30 year-on-year, with its share of the …

UK’s M&S Christmas food sales growth topped only by Lidl Read More »

BERLIN (Reuters) – BMW Group reported record sales of over 2.5 million units in 2023 and hit its target of a 15% share of battery-electric vehicles, the carmaker said on Tuesday. Fourth quarter sales reached 718,778 cars, up 10.3% from last year’s figures, with total annual sales up 6.5%.The U.S. saw the highest sales growth …

BMW hits 2023 sales target, on track for EV goals in 2024 Read More »

By Nick Carey LONDON (Reuters) – Stellantis said on Tuesday using Amazon’s computing power and BlackBerry technology it has developed a “virtual cockpit” to create and test new versions of car controls and systems in a day instead of months. Stellantis said that it can now create “realistic virtual versions of car controls and systems, …

Stellantis uses Amazon cloud to cut in-car software development to a day Read More »

(Reuters) -GSK on Tuesday said it would acquire asthma drug maker Aiolos Bio in a deal worth up to $1.4 billion, as the British drugmaker boosts its growing respiratory diseases portfolio. Founded in 2023, Aiolos is focused on developing therapies for respiratory and inflammatory conditions. It is currently developing ‘AIO-001’, a treatment for asthma which …

GSK boosts respiratory portfolio with $1.4 billion Aiolos Bio deal Read More »

DUBLIN (Reuters) – Talks on a new Irish public sector pay deal will resume between government and trade unions on Tuesday as unions finalise plans to ballot members on potential industrial action, the country’s largest public sector union said on Monday. Ireland has enjoyed broad industrial peace for over a decade thanks to successive pay …

Irish public sector pay talks to resume amid industrial action threat Read More »

By Bhanvi Satija and Sriparna Roy (Reuters) – Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, igniting what industry participants hope will be a strong year for deals after a solid end to 2023. Deals announced on Monday had …

Drugmakers kick off industry conference with two cancer deals Read More »

MILAN (Reuters) – Italian law firm PedersoliGattai, created from the merger of two Milanese legal firms, started operations on Jan. 1 with more than 350 lawyers, including 63 partners, it said on Monday. Carlo Pedersoli has been appointed chairman and Bruno Gattai was named managing partner. Both will sit on the executive committee together with …

Italian law firm PedersoliGattai starts operations after merger Read More »

By Svea Herbst-Bayliss and Anousha Sakoui NEW YORK/LONDON (Reuters) – Activist investors are expected to launch more and bolder campaigns for change among European companies in the year ahead, advisers told Reuters, after a record number in 2023. Europe was for years something of a backwater for activists as a company’s management often had closer …

Activist investors’ sights set on corporate Europe after record year Read More »

(Reuters) – Johnson & Johnson said on Monday it had agreed to buy drug developer Ambrx Biopharma for $2 billion to gain access to drugs that belong to a class of targeted cancer therapies which have drawn interest from other drugmakers. J&J will pay $28 per share of Ambrx, which represents a premium of about …

J&J to buy targeted cancer therapy developer Ambrx for $2 billion Read More »